Be Aware of Nuances When Using Phosphate Binders
September 2019
You'll be asked how to manage hyperphosphatemia during transitions of care in patients with severe chronic kidney disease.
High phosphorus levels cause hypocalcemia...which triggers parathyroid hormone release. This can lead to fractures, vascular calcification, etc...and is linked to increased mortality.
Expect maintenance binders to be saved for persistently elevated phosphate levels. Any binder can lower phosphorus levels by about 1 to 2 mg/dL...but none is shown to improve outcomes.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote